We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+2.66%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$905M
AUM Growth
-$258M
Cap. Flow
-$235M
Cap. Flow %
-25.96%
Top 10 Hldgs %
40.21%
Holding
233
New
72
Increased
5
Reduced
36
Closed
79

Top Buys

Rank Stock Value
1
KROS icon
Keros Therapeutics
KROS
+$23.4M
2
TIGO icon
Millicom
TIGO
+$7.17M
3
SIMO icon
Silicon Motion
SIMO
+$5.32M
4
ANEB
Anebulo Pharmaceuticals
ANEB
+$4.16M
5
CHARU
Charlton Aria Acquisition Corp Units
CHARU
+$3.66M

Top Sells

Rank Stock Value
1
JXN icon
Jackson Financial
JXN
+$37.5M
2
JOYY
JOYY Inc
JOYY
+$37.2M
3
ANAB icon
AnaptysBio
ANAB
+$23.1M
4
IBIT icon
iShares Bitcoin Trust
IBIT
+$15.7M
5
TSEM icon
Tower Semiconductor
TSEM
+$13.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.6%
2 Consumer Discretionary 16.13%
3 Financials 11.79%
4 Communication Services 11.74%
5 Technology 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INDV icon
176
Indivior Pharmaceuticals
INDV
$4.85B
– –
-1,156,010
Closed -$11.3M
JXN icon
177
Jackson Financial
JXN
$8.57B
– –
-410,630
Closed -$37.5M
KMI icon
178
Kinder Morgan
KMI
$70.3B
– –
-43,891
Closed -$970K
LNG icon
179
Cheniere Energy
LNG
$52.8B
– –
-5,002
Closed -$900K
META icon
180
Meta Platforms (Facebook)
META
$1.51T
– –
-1,754
Closed -$1M
MPC icon
181
Marathon Petroleum
MPC
$89.3B
– –
-5,139
Closed -$837K
NTRA icon
182
Natera
NTRA
$36.1B
– –
-7,463
Closed -$947K
NVST icon
183
Envista
NVST
$4.39B
– –
-43,885
Closed -$867K
OCUL icon
184
Ocular Therapeutix
OCUL
$1.85B
– –
-21,416
Closed -$186K
OKE icon
185
Oneok
OKE
$55.9B
– –
-10,579
Closed -$964K
ORCL icon
186
Oracle
ORCL
$346B
– –
-6,730
Closed -$1.15M
PHG icon
187
Philips
PHG
$25B
– –
-12,725
Closed -$385K
PODD icon
188
Insulet
PODD
$11.6B
– –
-4,781
Closed -$1.11M
PRCT icon
189
Procept Biorobotics
PRCT
$1.03B
– –
-10,223
Closed -$819K
PSX icon
190
Phillips 66
PSX
$82.5B
– –
-6,660
Closed -$875K
QETAR icon
191
Quetta Acquisition Corp Right
QETAR
– –
-20,584
Closed -$26.8K
RDNT icon
192
RadNet
RDNT
$4.97B
– –
-9,022
Closed -$626K
SHC icon
193
Sotera Health
SHC
$5.06B
– –
-13,757
Closed -$230K
SLN
194
Silence Therapeutics
SLN
$546M
– –
-385,408
Closed -$7.01M
SNN icon
195
Smith & Nephew
SNN
$13.7B
– –
-11,203
Closed -$349K
TAL icon
196
TAL Education Group
TAL
$5.79B
– –
-102,689
Closed -$1.22M
TBMC
197
DELISTED
Trailblazer Merger Corp I
TBMC
– –
-45,600
Closed -$502K
TSM icon
198
TSMC
TSM
$2.03T
– –
-5,301
Closed -$921K
UFPT icon
199
UFP Technologies
UFPT
$2B
– –
-754
Closed -$239K
WFC icon
200
Wells Fargo
WFC
$263B
– –
-16,722
Closed -$945K
6 7
8
9 10

Similar funds

GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Mangrove Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Mangrove Partners held 233 positions worth $905M, down 22% from $1.16B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Mangrove Partners withdrew a net $235M in Q4 2024, closing 79 positions and reducing 36 holdings. Its most notable exit was Jackson Financial, an estimated $37.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Mangrove Partners opened a new position in Millicom worth $6.84M.

  • Mangrove Partners's largest Q4 2024 buy was Millicom: 273,463 shares worth $6.84M.
  • Mangrove Partners added most to Keros Therapeutics in Q4 2024, an estimated $23.4M increase.
  • Mangrove Partners's biggest Q4 2024 reduction was Tower Semiconductor, cutting an estimated $13.2M.
  • Mangrove Partners fully exited Jackson Financial in Q4 2024, selling an estimated $37.5M.
  • Mangrove Partners's ten largest holdings make up 40% of its $905M portfolio in Q4 2024.
  • Mangrove Partners opened 72 new positions and closed 79 in Q4 2024.
  • Mangrove Partners's portfolio value fell 22% quarter-over-quarter to $905M.

Based on Mangrove Partners's 13F filing for Q4 2024, filed 14 Feb 2025.